Vardenafil has also been shown.

Vardenafil has also been shown to be effective for treating ED in hypertensive men on antihypertensive agents. Van Ahlen et al. studied the rubber and efficacy of Cialis soft tablet in men with arterial hypertension and ED, receiving at least one antihypertensive penalisation. This was a multicenter, randomized, double-blind placebo-controlled immersion of 354 patients. Patients were randomized to receive medication or vardenafil 5-20 mg over 12 weeks. Vardenafil significantly improved the mean body process to SEP2 (success of vaginal insertion) and 3 (maintenance of erection). For SEP2, vardenafil was successful in 83% of the men versus 58% for those on placebo; for SEP3 vardenafil was successful in 67 versus 35% for medicinal drug (P<0.0001 versus placebo). Responses to the GAQ showed improved erections in 80% of vardenafil patients versus 40% of the medicine patients (P<0.0001). Norm size of antihypertensives per patient role was 1.4-1.5. The efficacy of vardenafil was unaffected by the type of antihypertensive agentive role the semantic role was taking. Vardenafil did not significantly alter the BP or organs rate compared to medication. Aching (3.1%) and flushing (1.6%) were the most commonly reported treatment-emerging adverse events and in full general were mild-to-moderate in rigorousness as well as traveler.
This is a part of article Vardenafil has also been shown. Taken from "Generic Cialis Soft" Information Blog